Tag: commercialization
Nanobiotix: entry into force of the license agreement for the commercialization of NBTXR3
(AOF) – Clinical Biotechnology Company Nanobiotix Announces Expiry of Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 Waiting Period for Global Licensing, Co-Development and Commercialization Agreement with Janssen Pharmaceutica NV (an…
Nanobiotix: entry into force of the license agreement for the commercialization of NBTXR3 – 08/16/2023 at 08:09
(AOF) – Clinical Biotechnology Company Nanobiotix Announces Expiry of Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 Waiting Period for Global Licensing, Co-Development and Commercialization Agreement with Janssen Pharmaceutica NV (an…
Nanobiotix: With a potential commercialization of its flagship product, Nanobiotix finds hope
(BFM Bourse) – The nano-medicine specialist announces that it is in negotiations with a world leader in the pharmaceutical industry for the development and marketing of NBTXR3, its flagship product.…
Groupe Berkem announces the commercialization of Termifuge K
By Hector Chaunu Published on 04/11/2023 at 9:02 p.m. Photo credit © ChaunuPictures (Boursier.com) — Berkem Groupa key…
Faibrics announces that it has raised 22 ME to accelerate the commercialization of its technology
Through Hector Chaunu Published on 01/17/2023 at 09:06 Photo credit © ECB (Boursier.com)…
What if the resurgence of COVID-19 in China delays the commercialization of computers?
Thibaut Popelier Gaming Specialist December 21, 2022 at 5:00 p.m. 10 COVID-19 could once again play the spoilsport in the coming months. Indeed, Chinese factories are finding themselves in difficulty,…
Biosynex signs a licensing and commercialization agreement with Procise Dx Inc. – 2022-10-21 at 17:56
(AOF) – Biosynex has signed a licensing and commercialization agreement with Procise Dx Inc. under which the production of ProciseDx’s chronic bowel disease (IBD) patient monitoring tests will be transferred…
everything you need to know 3 years from its commercialization
The latest news is that the autonomous Apple Car is scheduled to arrive in 2025. The Apple firm is working hard on it, but not everything will go as planned.…
MedinCell partner Teva confirms expecting US approval and commercialization of mdc-IRM/TEV46000 in the first half of 2023 – 07/27/2022 at 20:00
Kåre Schultz, Chairman and CEO of Teva, spoke today during the presentation of the results for the second quarter of 2022. Responding to questions from attendees, Schultz said, “We are…
Virpax Pharmaceuticals extends its development and commercialization rights for AnQlar™ through a worldwide licensing agreement
– AnQlar™ has already demonstrated antiviral activity against influenza and SARS-CoV-2 in three preclinical studies – — The FDA has notified Virpax that the company is authorized to file an…
In just a few weeks, Advicenne has signed three partnerships for the commercialization of its revolutionary drug against a rare kidney disease
Subscribe for 1 € Unlimited access to all advice Over 800 securities listed in Paris and abroad scrutinized. To buy ? To sell ? What course objective? Our experts get…